Pleomorphic lobular carcinoma in situ: A divergent entity with emerging significance

Oncology

Volumn 25, Issue 4, 2011, Pages

  Chivukula, Mamatha ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P120; RALOXIFENE; TAMOXIFEN; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; CANCER SURGERY; CHROMOSOME DELETION; CHROMOSOME LOSS; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LOBULAR CARCINOMA IN SITU; MAMMOGRAPHY; NEEDLE BIOPSY; PROTEIN EXPRESSION; RISK REDUCTION;

EID: 79956198324     PISSN: 08909091     EISSN: 08909091     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Cornil AV. Les tumeurs du sein. Paris, France, Libraire Germer, 1908.
2. Page DL, Dupont WD, Rogers LW, et al. Atypical hyperplastic lesions of the female breast: a long-term follow-up study. Cancer. 1985;55:2698-2708.
3. Page DL, Rogers LW. Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia. Hum Pathol. 1992;23:1095-7.
4. O'Malley FP. Lobular neoplasia: morphology, biological potential and management in core biopsies. Mod Pathol. 2010;23(Suppl 2):S14-25.
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
6. Rosen PP, Braun DW Jr, Lyngholm B, et al. Lobular carcinoma in situ of the breast: preliminary results of treatment by ipsilateral mastectomy and contralateral breast biopsy. Cancer. 1981;47:813-19.
7. Rosen PP, Senie R, Schottenfeld D, et al. Noninvasive breast carcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg. 1979;189:377-82.
8. Urban JA. Bilaterality of cancer of the breast: biopsy of the opposite breast. Cancer. 1967;20:1867-70.
9. Georgian-Smith D, Lawton TJ. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol. 2001;176:1255-9.
10. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000;436:421-30.
11. Gao F, Carter G, Tseng G, Chivukula M. Clinical importance of histologic grading of lobular carcinoma in situ (LCIS) on breast core needle biopsies. Current issues and controversies. Am J Clin Pathol. 2010;133:767-71.
12. Carley AM, Chivukula M, Carter GJ, et al. Frequency and clinical implications of simultaneous association of lobular neoplasia with columnar cell alterations in breast tissue specimens. Am J Clin Pathol. 2008;130:254-8.
13. Rakha EA, El-Sayed ME, Menon S, et al. Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2008;111:121-7.
14. Bentz JS, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol. 1998;11:814-822.
15. Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000;24:1650-6.
16. Frost AR, Tsangaris NT, Silverberg SG. Pleomorphiclobular carcinoma in situ, in Silverberg SG (ed): Pathology Case Reviews, vol. 1. Philadelphia, Lippincott Williams & Wilkins, 1996, pp 27-31.
17. Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002;15:1044-50.
18. Chivukula M, Haynik DM, Brufsky A, et al. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Am J Surg Pathol. 2008;32:1721-6.
19. Chivukula M, Brufsky A, Carter G, et al. Molecular alterations in pleomorphic lobular carcinoma in situ (PLCIS) (abstract 5004). Cancer Res. 2009;69.
20. Reis-Filho JS, Simpson PT, Jones C, et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol. 2005;207:1-13.